Description
Xgeva 120mg/1.7ml Injection: A Comprehensive Overview
Xgeva 120mg/1.7ml Injection contains Denosumab, a human monoclonal antibody. Doctors use this crucial biologic primarily to prevent skeletal-related events (SREs) in individuals with bone metastases originating from solid tumors. SREs include complications such as pathological fractures, spinal cord compression, and the need for radiation or surgery to the bone. Denosumab works by a highly specific mechanism. It actively inhibits the Receptor Activator of Nuclear Factor-kappa B Ligand (RANKL). Consequently, blocking RANKL reduces the activity and formation of osteoclasts, which are the cells responsible for bone breakdown. This action effectively reduces bone resorption, thereby strengthening the bone structure.
Usage, Administration, and Therapeutic Protocols
A healthcare provider administers this injection subcutaneously (under the skin) once every four weeks. This is typically done under the close supervision of an oncologist or specialized nurse in a clinical setting. The consistent, four-week schedule is crucial for maintaining the therapeutic blockade of RANKL. Xgeva is particularly useful in oncology settings because it minimizes complications like fractures, spinal compression, and the need for palliative bone procedures. Furthermore, the goal of the treatment is to delay the onset of SREs and ultimately improve the patient’s quality of life.
Manufacturing, Safety, and Monitoring
Dr. Reddy’s manufactures Xgeva Denosumab 120mg Injection. While it is an essential part of cancer supportive care, a patient may experience some side effects. Common adverse effects may include fatigue, muscle pain, and importantly, low calcium levels (hypocalcemia). Hypocalcemia is a significant risk, especially in patients with pre-existing kidney issues. For this reason, doctors consider regular monitoring of calcium, phosphorus, and magnesium levels essential during treatment. They often prescribe calcium and vitamin D supplements to mitigate the risk of hypocalcemia.
Availability & Purchase Information
Genetec Lifesciences makes Xgeva Denosumab 120mg Injection available. All medicines are sourced directly from Dr. Reddy’s or its authorized distributors.
Disclaimer
This site provides product information for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or its authorized vendors.